Literature DB >> 30007465

Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features.

Jonathan J Lyons1.   

Abstract

Hereditary alpha tryptasemia is an autosomal dominant genetic trait caused by increased germline copies of TPSAB1 encoding alpha-tryptase. Individuals with this trait have elevated basal serum tryptase, and may present with associated multisystem complaints. Both basal serum tryptase levels and severity of clinical symptoms display a gene-dose relationship with TPSAB1, whereby higher tryptase levels and greater symptom severity are correlated with increasing numbers of alpha-encoding TPSAB1. As the functional effects of increased basal serum tryptase and/or altered tryptase gene expression are elucidated, greater insights will be gained into the symptoms associated with hereditary alpha tryptasemia and their potential therapy. Published by Elsevier Inc.

Entities:  

Keywords:  Autosomal dominant; Genotyping; Hypertryptasemia; Mast cell activation

Mesh:

Substances:

Year:  2018        PMID: 30007465      PMCID: PMC6411063          DOI: 10.1016/j.iac.2018.04.003

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  28 in total

Review 1.  Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations.

Authors:  Paneez Khoury; Jonathan J Lyons
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

2.  Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in trans.

Authors:  Sarah C Glover; Alexander Carlyle; Jonathan J Lyons
Journal:  Ann Allergy Asthma Immunol       Date:  2021-12-09       Impact factor: 6.347

Review 3.  Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.

Authors:  Sarah C Glover; Melody C Carter; Peter Korošec; Patrizia Bonadonna; Lawrence B Schwartz; Joshua D Milner; George H Caughey; Dean D Metcalfe; Jonathan J Lyons
Journal:  Ann Allergy Asthma Immunol       Date:  2021-08-13       Impact factor: 6.248

Review 4.  Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.

Authors:  Joana Caiado; Mariana C Castells
Journal:  Curr Allergy Asthma Rep       Date:  2021-07-07       Impact factor: 4.806

5.  New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on Mastocytosis (ECNM) 2019.

Authors:  Michel Arock; Karl Sotlar; Jason Gotlib; Wolfgang R Sperr; Karin Hartmann; Lawrence B Schwartz; Cem Akin; Hans-Peter Horny; Peter Valent
Journal:  Leuk Lymphoma       Date:  2019-12-26

6.  Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis.

Authors:  Allyson Mateja; Qinlu Wang; Jack Chovanec; Jiwon Kim; Kenneth J Wilson; Lawrence B Schwartz; Sarah C Glover; Melody C Carter; Dean D Metcalfe; Erica Brittain; Jonathan J Lyons
Journal:  J Allergy Clin Immunol       Date:  2021-08-20       Impact factor: 14.290

7.  Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia.

Authors:  Liza Konnikova; Tanya O Robinson; Anna H Owings; James F Shirley; Elisabeth Davis; Ying Tang; Sarah Wall; Jian Li; Mohammad H Hasan; Raad Z Gharaibeh; Lybil B Mendoza Alvarez; Lisa K Ryan; Andria Doty; Jack F Chovanec; Michael P O'Connell; Dianne E Grunes; William P Daley; Emeran Mayer; Lin Chang; Julia Liu; Scott B Snapper; Joshua D Milner; Sarah C Glover; Jonathan J Lyons
Journal:  J Allergy Clin Immunol       Date:  2021-04-15       Impact factor: 14.290

8.  Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome.

Authors:  Matthew J Hamilton; Melissa Zhao; Matthew P Giannetti; Emily Weller; Raied Hufdhi; Peter Novak; Lybil B Mendoza-Alvarez; Jason Hornick; Jonathan J Lyons; Sarah C Glover; Mariana C Castells; Olga Pozdnyakova
Journal:  Am J Surg Pathol       Date:  2021-07-01       Impact factor: 6.298

9.  Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.

Authors:  Georg Greiner; Bettina Sprinzl; Aleksandra Górska; Franz Ratzinger; Michael Gurbisz; Nadine Witzeneder; Klaus G Schmetterer; Bettina Gisslinger; Goekhan Uyanik; Emir Hadzijusufovic; Harald Esterbauer; Karoline V Gleixner; Maria T Krauth; Michael Pfeilstöcker; Felix Keil; Heinz Gisslinger; Boguslaw Nedoszytko; Marek Niedoszytko; Wolfgang R Sperr; Peter Valent; Gregor Hoermann
Journal:  Blood       Date:  2021-01-14       Impact factor: 22.113

Review 10.  Inherited and acquired determinants of serum tryptase levels in humans.

Authors:  Jonathan J Lyons
Journal:  Ann Allergy Asthma Immunol       Date:  2021-06-24       Impact factor: 6.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.